8 healthcare startup and investor trends at JPM17 from inverting business models to second order companies 1


Last week’s 35th annual J.P. Morgan Healthcare conference in San Francisco was packed with thousands of healthcare investors, analysts, large multinational healthcare companies, startups, and everything in between.

It was fascinating and enlightening to have private one-on-one time with so many startups, large global healthcare companies, hospital systems, and pharmaceutical companies. As well, it was great to catch up with so many angel, seed, and Series A investors. From these meetings, several trends emerged. Some were new learnings while several were amplifications of what we see in our work at Dreamit Health when building and accelerating dozens of post-seed digital health and medical device startups every year.

Here are eight early stage related trends spotted at the conference:

  • The big data trend is very strong and growing;
  • Diagnostic companies are conducting earlier validation studies;
  • Disruptive innovation is relying on model inversion;
  • Second order companies are emerging;
  • Corporate interest in startups is expanding;
  • Strategic investors are trying several approaches to be more innovative;
  • Seed funds want to invest in at least the same country; and
  • Corporate venture capital investors are investing strategically and globally.

 

Read the rest medcitynews.com


Leave a Reply

One thought on “8 healthcare startup and investor trends at JPM17 from inverting business models to second order companies